甘精胰岛素的全科门诊应用(2)
![]() |
第1页 |
参见附件。
5 2010年版中国2型糖尿病防治指南.
6 Riddle MC,et al.Diabetes Care published online October 25,2011.
7 Lawes CM,Parag V,Bennett DA,et al.Blood glucose and risk of cardiovascular disease in the Asia Pacific region.Diabetes Care.2004;27:2836-2842.
8 Nazimek-Siewniak B,Moczulski D,Grzeszczak W.Risk of macrovascular and microvascular complications in Type 2 diabetes:results of longitudinal study design.J Diabetes Complications.2002,18:271-276.
9 Pang Can,Bao YQ,Wang C,et al.Relationship between the level of fasting plasma glucose and beta cell functions in Chinese with or without diabetes.Chin Med J,2008,121:2119-2123.
10 John D,Robertson RP,Lerner RL,et al.Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests.J Clin Endocrinol Metab 1976,42:222-229.
11 Pennartz C,Schenker N,Menge BA,et al.Chronic reduction of fasting glycemia with insulin glargine improves first- and second-phase insulin secretion in patients with type 2 diabetes.Diabetes Care,2011,34:2048-2053.
12 Zeng LY,et al.Diabetes Technol &Ther DOI:10.1089/dia.2011,1:23.
您现在查看是摘要介绍页,详见PDF附件。